BlackRock, Inc. 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 6:13 pm Sale | 2025-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | BlackRock Inc. BLK | 8,580,553 5.900% | -1,895,530 (-18.09%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | BlackRock Inc. BLK | 10,476,083 7.400% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | BlackRock Inc. BLK | 10,476,083 7.400% | 10,476,083 (New Position) | Filing |